Enhancement of immune responses by 4-1BB-binding agents
US8163550B2 · kind B2 · utility
16Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2009 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | Nov 6, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention features methods of enhancing immune responses in mammalian subjects and in vitro methods of enhancing the response of a T cell. Also embodied by the invention are methods of receiving and preventing the induction of energy in T cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.